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Abstract
I In nt tr ro od du uc ct ti io on n: :   The aim of this study was to investigate the relationship between
the admission blood glucose level following acute poisoning, severity of acute
poisoning and clinical outcome. 
M Ma at te er ri ia al l   a an nd d   m me et th ho od ds s: :   This prospective study was conducted on 345 deliberate
self-poisoning  patients.  Standard  demographic  and  clinical  information;
admission blood glucose level; poisoning severity score and outcome were
recorded. Patients with a history of diabetes mellitus, receipt of pre-sampling
intravenous dextrose solution or glucocorticoids, and poisoning with toxic agents
which produce hyper- or hypoglycaemia were excluded. 
R Re es su ul lt ts s: :   Mean age of the patients was 27.5 ±8.6 years. Females outnumbered
males (57.9%). Oral ingestion of more than one drug (46.7%) and opiates (14.2%)
were the main causes of poisoning. Blood glucose values ranged from 50 mg/dl
to 396 mg/dl. Hyper- and hypoglycaemia were observed in 23.8% and 13.91%
respectively. A total of 24.41% and 22.92% of the patients in hyper- and
hypoglycaemic groups had grade 3 and 4 severity score in comparison with
4.18% in the normoglycaemic group. Development of complications and death
were 14.64% and 10.42% in patients with hyper- and hypoglycaemia versus
3.73% in patients with normoglycaemia. A significant difference between
normoglycaemic and hyperglycaemic patients in the severity of poisoning and
clinical outcome was observed (P < 0.001). 
C Co on nc cl lu us si io on ns s: :   Admission blood glucose levels may have a relationship with the
severity of poisoning and clinical outcome following acute poisoning. 
K Ke ey y   w wo or rd ds s: :   blood glucose, acute poisoning, outcome, poisoning severity score,
hyperglycaemia.
Introduction
Hyperglycaemia is a common problem in hospitalized patients with or
without a history of diabetes mellitus [1, 2]. The increased requirement of the
brain, heart, immune system and other tissues for glucose during stressful
situations is associated with alteration in metabolic activity [3]. It has been
proposed that stress has major effects on glucose metabolism through the
activation and interaction of immunoneuroendocrine systems which result
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in hyperglycaemia and insulin resistance [4]. The
major causes of hyperglycaemia include increased
release of stress hormones referring to counter-
regulatory hormones (epinephrine, norepinephrine,
glucagon, growth hormone, beta-endorphin and
cortisol), overproduction of proinflammatory cytoki  -
nes (especially tumour necrosis factor-α, interleu-
kin-1 and -6), iatrogenic factors (administration of
steroids, catecholamines and excess dextrose by total
parental nutrition) and underlying disease states
[5-10]. A growing body of evidence suggests that
hyperglycaemia is associated with increased mor  -
bidity and mortality, and poor prognostic outcomes
in critical illness [11-13]. 
It is noteworthy that various therapeutic agents
have been implicated as diabetogenic factors. These
drugs influence glucose metabolism and cause
hyperglycaemia through multiple mechanisms of
action [14]. Although marked blood glucose levels
are generally uncommon with therapeutic doses of
most  of  these  medications,  higher  doses  and
intoxications are more likely to be accompanied by
severe hyperglycaemia. The most common me  di  -
cations are shown in Table I [15-18]. Moreover, one
of the reported adverse effects in organo  phosphate,
carbamate and amitraz poisoning is hyperglycaemia
[19-21].
On the other hand, several medications may
reduce blood glucose levels. These agents are also
shown in Table I [14].  
Despite extensive clinical investigations about
hyperglycaemia  in  both  medical  and  surgical
intensive care units (ICUs), to our best knowledge,
stress hyperglycaemia due to poisoning has not
been described previously. Also we have not found
any  study  on  poisoned  patients  to  show  the
admission blood glucose level with respect to
poisoning severity score and outcome especially
when  medication-induced  hyperglycaemia  or
hypoglycaemia were excluded. 
Therefore the purpose of this study was to
describe the relationship between admission blood
glucose levels with severity of poisoning and clinical
outcome following acute poisoning. 
Material and methods
This prospective study was conducted in the
Department of Poisoning Emergency and Clinical
Toxicology of Noor Hospital, Isfahan University of
Medical Sciences (Iran) from March 2005 to May
2005. A total of 345 adult deliberate self-poisoning
patients, aged 18 years or over, were included.
Exclusion criteria were a history of diabetes mellitus,
receipt  of  presampling  intravenous  dextrose
solution or glucocorticoids, and poisoning with
medications or toxic agents which produce hyper-
or hypoglycaemia as mentioned in the introduction.
The  protocol  was  approved  by  the  bioethics
committee of the Isfahan University of Medical
Sciences. 
D Da at ta a   c co ol ll le ec ct ti io on n   
Demographic and clinical information, including
toxic agent, the time elapsed from poisoning until
arrival at the emergency department, severity of
the  poisoning  and  outcomes  were  recorded
prospectively in a dedicated database. 
The clinical severity of poisoning was graded
according to the method described by Persson
and coworkers, and developed by the Interna  -
tional Program on Chemical Safety, the European
Community, and the European Association of
Poisons  Centres  and  Clinical  Toxicologists
(IPCS/EC/EAPCCT). The poisoning severity score
(PSS) is a four-scale grading as (0) none, (1) minor,
(2) moderate, (3) severe, and (4) fatal [22, 23]. It
was determined at the time of initial inquiry and
following recovery, using examination findings
including the Glasgow coma score, pupil size,
convulsion, res  pira  to  ry rate, pulse rate, blood
pressure, body tem  perature, electrocardiogram
(ECG) findings, pain assessment, and laboratory
presentations (serum glucose, potassium, sodium,
pH, and bicarbonate in arterial blood gases). 
All patients received medical treatment under
the  direction  of  the  hospitals’  consultant
physicians. The clinical outcome measures were
described as recovery without complications,
complications (respiratory, renal and liver failure)
and death. 
H Hy yp pe er rg gl ly yc ca ae em mi ic c   d dr ru ug gs s H Hy yp po og gl ly yc ca ae em mi ic c   d dr ru ug gs s
Calcium channel blockers  Salicylates
Glucocorticoids   β-2 agonists                          
Hydrochlorothiazide Acetaminophen
Isoniazid Non-selective β-blockers                
Chlorpromazine Quinine
β-adrenergic agonists Quinidine
β-blockers Captopril
Niacin Imipramine 
Theophylline Clofibrate
Morphine Lithium 
Amoxapine
Dopamine and its analogues
Organophosphate
Carbamate
Amitraz
T Ta ab bl le e   I I. . Drugs which influence blood glucose level
and were excluded from this studyArch Med Sci 1, February / 2011 83
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Respiratory failure was diagnosed by monitoring
arterial blood gases (ABGs) and chest X-ray. Also
patients who were hypoxic in spite of oxygen
through nasal cannula received oxygen by mask 
(5-10 l/min). The indication for intubation was
hypoxia unresponsive to supplemental oxygen
through nasal cannula or mask. Patients who failed
to respond to supplemental oxygen were intubated
and ventilated under the direction of critical care
physicians. Acute renal failure was defined as serum
creatinine > 2.0 mg/dl. Liver failure was defined as
highly elevated serum aminotransferase enzymes
(compared to the normal baseline). 
G Gl lu uc co os se e   m me ea as su ur re em me en nt ts s   
Blood samples were obtained on admission and
if there was hyperglycaemia, subsequent blood
samples were taken every 4 hr for 12 hr or more if
needed. In cases of hypoglycaemia, glucose level
was checked every hour by glucometer until the
normal blood glucose levels were obtained. The
serum  glucose  level  was  measured  using  the
glucose oxidase method on a Technicon RA-1000
Auto Analyzer (Bayer Diagnostics, Ireland). The
range of admission blood glucose levels was divided
into hypoglycaemic (< 70 mg/dl), normoglycaemic
(70-126 mg/dl), and hyperglycaemic (> 126 mg/dl)
ranges [24]. 
S St ta at ti is st ti ic ca al l   a an na al ly ys si is s
Glucose values were evaluated as a continuous
variable and also as hypoglycaemic, nor  mo  gly  -
caemic  and  hyperglycaemic  grades.  Statistical
analysis was performed by χ2, Mann-Whitney U and
Kruskal Wallis, and Spearman correlation tests
using  the  SPSS  13.0  software.  P <  0.05  was
considered as the statistically significant level. 
Results
B Ba as se el li in ne e   c ch ha ar ra ac ct te er ri is st ti ic cs s      
Demographic and clinical characteristics of 345
patients who met the inclusion criteria for the study
are presented in Table II. Females outnumbered
males and mean age was 27.5 ±8.6 years (range:
18-65 years). Multi-drug abuse was the main cause
of poisoning in the studied population (46.7%).
Opiates (14.2%) and benzodiazepines (11.9%) were
the most frequently used drugs. The majority of
cases (50%) were grade 0 PSS (no symptoms or
signs) and only 11% and 0.6% were grade 3 and 4,
respectively (severe and fatal). 
C Cl li in ni ic ca al l   o ou ut tc co om me es s   
Complete recovery was observed in 92.7% of
patients, 6.7% developed complications and 0.6%
died.  Aspiration  pneumonitis  was  the  most
frequently  observed  complication.  The  PSS 
was significantly correlated with clinical outcomes
(Spearman  correlation  coefficient  =  0.371, 
p < 0.001).
No. of patients 345
Age [year] 27.5 ±8.6
Gender
Female 200 (57.9)
Time elapsed after poisoning [hour] 2.8 ±0.34
Clinical status
Aware 164 (47.5)
Sleepy 67 (19.4)
Stupor 82 (23.8)    
Coma 32 (9.3)
Admission blood glucose [mg/dl] 115.9 ±3.9 
Severity of poisoning
No symptoms or signs 169 (50)
Mild 78 (22.6)
Moderate 58 (16.8)
Severe 38 (11)
Fatal 2 (0.6)
Outcome
Death  2 (0.6)
Recovery 320 (92.7)
Complications 23 (6.7)
Respiratory failure 13 (3.8)
Renal failure 6 (1.7)
Liver failure 4 (1.2)
Substance (toxins)         
Multi-drug 161 (46.7)
Opiates 49 (14.2)
Benzodiazepines 41 (11.9)
Analgesics 23 (6.7)
Antiepileptics 19 (5.5)
Antidepressants 9 (2.6)
Psychoactives 8 (2.3)
Cardiovascular 8 (2.3)  
Cannabinoids 7 (2.0)
Corrosives 7 (2.0)   
Alcohols 6 (1.7)
Other 7 (2.0) 
T Ta ab bl le e    I II I. . Baseline and clinical characteristics of
patients 
Data are expressed as mean ± SEM or n (%). Multi-drug poisoning
included various combinations of sedative-hypnotic, antidepressant,
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B Bl lo oo od d   g gl lu uc co os se e   l le ev ve el ls s
Blood glucose values ranged from 50 mg/dl to
396 mg/dl (mean 115.9 ±3.9 mg/dl). Hyperglycaemia
and hypoglycaemia were observed in 23.8% and
13.91% respectively. In all hyperglycaemic patients,
subsequent measurements of blood glucose show
a trend to attenuation and normoglycaemia after
supportive care. No medications were used to
control hyperglycaemia. All patients with hypo  -
glycaemia  received  infusion  of  0.5-1  g/kg  of
hypertonic dextrose to obtain a normal blood
glucose level. The incidence of hypo-, normo- and
hyperglycaemic cases in various grades of poisoning
and  clinical  outcomes  are  shown  in  Tables  III 
and IV. The correlations of blood glucose levels with
other collected data were evaluated. There was no
significant correlation using Spearman correlation
test between blood glucose level and age (p = 0.13),
gender (p = 0.054), time of arrival (p = 0.092) and
toxin agent (p = 0.32). A total of 24.41% and 
22.92 % of the patients in hyper- and hypo  gly  -
caemic groups had grade 3 and 4 severity score in
comparison with 4.18% in the normoglycaemic
group (Table III). Development of complications and
death were 14.64% and 10.42% in patients with
hyper- and hypoglycaemia versus 3.73% in patients
with  normoglycaemia.  A significant  difference
between  normoglycaemic  and  hyperglycaemic
patients was observed in the severity of poisoning
and clinical outcome (P < 0.001) (Table IV, Figure 1). 
Discussion
In this prospective study, significant differences
in the severity of poisoning were observed in the
hyperglycaemic patients compared with normo  -
glycaemic patients. The patients with hypo- and
hyperglycaemia showed higher grades of PSS. Cases
in grade 4 (fatal) were only in the hyperglycaemic
group. Adverse clinical outcome (complications and
death) was more often present in patients with
hyperglycaemia. Evaluation of acute poisoning-
induced hyperglycaemia revealed that admission
blood glucose levels may be a predictor of hospital
morbidity and mortality following acute poisoning. 
Demographic and clinical data of the present
study showed that young people and females were
more vulnerable to self-poisoning. In other studies,
suicide has also been mostly dominant in young
adults. Gender differences have been reported in
some  studies  and  most  of  the  self-poisoned
patients have been female [25, 26]. Multi-drug
poisoning was found to be the most common type
of poisoning. Because most of the patients were
admitted within early hours after intoxication, there
was no significant correlation between time of
poisoning and hyperglycaemia. 
Since all medications poisoning by which is
known to influence blood glucose levels were
excluded from our study, there was no significant
correlation between toxin agent and admission
blood glucose level. Because of exclusion of diabetic
patients and poisoning with hyperglycaemic agents,
it may be concluded that hyperglycaemia was
induced by stress of poisoning. Attenuation of blood
glucose levels in subsequent measurements in
hyperglycaemic patients after supportive care also
suggests the role of stress in the hyperglycaemic
condition in some poisoned patients. Most patients
improved completely without complications, and
the mortality rate was 0.6%. It is noteworthy that
several high-risk patients, who had made a suicide
B Bl lo oo od d   g gl lu uc co os se e P Po oi is so on ni in ng g   s se ev ve er ri it ty y   s sc co or re es s T To ot ta al l
[ [m mg g/ /d dl l] ] 0 0 1 1 2 2 3 3 4 4
70-126 130 (60.47) 50 (23.25) 26 (12.10) 9 (4.18) 215 (100)
< 70 7 (14.58) 14 (29.16) 16 (33.34) 11 (22.92) 48 (100)
> 126 32 (39.01) 14 (17.07) 16 (19.51) 18 (21.95) 2 (2.46) 82 (100)
Poisoning severity score was graded as (0) none, (1) minor, (2) moderate, (3) severe, and (4) fatal. Data are expressed as n (%)
T Ta ab bl le e   I II II I. .   Admission blood glucose levels in the poisoning severity score groups 
B Bl lo oo od d   g gl lu uc co os se e C Cl li in ni ic ca al l   o ou ut tc co om me e T To ot ta al l
[ [m mg g/ /d dl l] ] 1 1 2 2 3 3
70-126 207 (96.27) 8 (3.73) 215 (100)
< 70 43 (89.58) 5 (10.42) 48 (100)
> 126 70 (85.36) 10 (12.20) 2 (2.44) 82 (100)
Clinical outcome was graded as (1) recovery without complications, (2) recovery with complications, and (3) death. Data are expressed as n (%)
T Ta ab bl le e   I IV V. .   Poisoning severity score was graded as (0) none, (1) minor, (2) moderate, (3) severe, and (4) fatalArch Med Sci 1, February / 2011 85
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attempt with an antihypertensive medication or
some insecticides and pesticides (as a predictor of
ICU admission) were excluded from this study
because of induction of glucose tolerance disorders
[25, 27]. 
Although poisoning is one of the important
causes of significant morbidity and mortality, and
appropriate  management  is  very  important  in
critically ill poison patients [28], acute poisoning-
induced hyperglycaemia has not been previously
studied in these patients. The results of various
studies in critically ill patients have shown that
stress-induced hyperglycaemia is a strong predictor
of increased mortality and adverse clinical outcome
[1, 5, 13]. Hyperglycaemia is found to be associated
with increased risk of infectious complications 
and  septic  shock,  reduced  immune  response,
dehydration and electrolyte imbalances and lethal
multiple  organ  failure  in  traumatic  and  acute
ischaemic events [12, 29, 30].
Some toxicological studies have been performed
on medications or toxic agents which influence
blood glucose levels. Hyperglycaemia has been
related to adverse neurological outcome and brain
damage in acute severe carbon monoxide poisoning
[31]. In acute aluminium phosphide poisoning,
hyperglycaemia as a potential prognostic factor has
been correlated with mortality [32]. Hyperglycaemia
is also the outcome of acute or chronic exposure
to organophosphorus compounds [19]. In overdoses
of calcium channel blocker agents, serum glucose
concentrations correlate directly with the severity
of the calcium channel blocker intoxication [33].
Various clinical investigations in both medical
and surgical ICUs have confirmed that maintaining
normoglycaemia can improve the prognosis in
critical illness [1, 5, 11]. Insulin remains the obvious
treatment for hyperglycaemia and lowering blood
glucose levels to 80-110 mg/dl has a pivotal role in
the treatment of such patients [34]. Prevention of
the inflammatory process and insulin resistance
may also be important for the improvement of
critically ill patients with acute hyperglycaemia 
[5, 35]. Although the role of treatment of hyper  -
glycaemia with insulin and metformin has been
evaluated in critically ill patients in the studies by
Goldberg  and  Mojtahedzadeh,  none  of  these
modalities was performed in poisoning cases.
A large  randomized  controlled  trial  study  is
necessary to affirm the role of insulin or metformin
treatment in admission hyperglycaemia induced by
severe poisoning. 
Although poisoning cases with toxic agents
which produce hypoglycaemia were excluded from
our study, hypoglycaemia was also observed in
13.91%  of  patients.  However,  there  was  no
relationship between hypoglycaemia and severity
of poisoning. We have no explanation for this. Since
hypoglycaemia recovered after 0.5-1 g/kg infusion
of hypertonic dextrose, the poor nutrition of suicidal
patients may be one of the reasons (because of an
argument with their family they had not eaten
lunch or dinner before the suicide attempt). 
In conclusion, acute poisoning-induced hyper  -
glycaemia may be a good predictor of severity of
poisoning and clinical outcome. However, further
studies for the optimal care of critically poisoned
patients with hyperglycaemia and multi-disciplinary
approaches to decrease the mortality rate among
these patients are needed.
The main limitation of our study is that it was
performed in a single medical centre in a non-
randomized design and underlying disease states
as  a risk  factor  for  hyperglycaemia  were  not
considered other than diabetes mellitus.
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